AXIOS January 1, 2025
Losing weight in the new year won’t take the same shape as it did in the past.
Why it matters: The emergence of groundbreaking new weight-loss drugs is transforming how Americans shed pounds.
- Nearly 18 million Americans are expected to be taking versions of GLP-1 drugs by 2029, according to investment bank UBS.
By the numbers: The drugs — which are currently administered in the form of regular injections — may already be reversing America’s obesity crisis.
- In a survey conducted from 2021 through 2023, 40.3% of adults 20 and older were classified as having obesity, down from the all-time high of 41.9% from 2017 through 2020.
- The data from the National Health and Nutrition Examination Survey...
Today's Sponsors
Today's Sponsor